Nucleosides and nucleotides. 185. Synthesis and biological activities of 4'α-C-branched-chain sugar pyrimidine nucleosides

Journal of Medicinal Chemistry

Volumn 42, Issue 15, 1999, Pages 2901-2908

  Nomura, Makoto ^a,b   Shuto, Satoshi ^a   Tanaka, Motohiro ^c   Sasaki, Takuma ^c   Mori, Shuichi ^d   Shigeta, Shiro ^d   Matsuda, Akira ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYCYTIDINE; PYRIMIDINE NUCLEOSIDE; URIDINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG ACTIVITY; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL; MOUSE; NONHUMAN;

ANIMALS; ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CARBOHYDRATES; DRUG SCREENING ASSAYS, ANTITUMOR; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HIV-1; HUMANS; INHIBITORY CONCENTRATION 50; MICE; PYRIMIDINE NUCLEOSIDES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0033614990     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm990050i     Document Type: Article

References (24)

1. Takenuki, K.; Matsuda, A.; Ueda, T.; Sasaki, T.; Fujii, A.; Yamagami, K. Design, synthesis, and antineoplastic activity of 2′-deoxy-2′-methylidenecytidine. J. Med. Chem. 1988, 31, 1063-1064.
2. Matsuda, A.; Takenuki, K.; Tanaka, M.; Sasaki, T.; Ueda, T. Synthesis of new broad-spectrum antineoplastic nucleosides, 2′-deoxy-2′-methylidenecytidine (DMDC) and its derivatives. J. Med. Chem. 1991, 34, 812-819.
3. Yamagami, K.; Fujii, A.; Arita, M.; Okumoto, T.; Sakata, S.; Matsuda, A.; Ueda, T.; Sasaki, T. Antitumor activity of 2′-deoxy-2′-methylidenecytidine, a new 2′-deoxycytidine derivatives. Cancer Res. 1991, 51, 2319-2323.
4. Matsuda, A.; Nakajima, Y.; Azuma, A.; Tanaka, M.; Sasaki, T. 2′-C-cyano-2′-deoxy-1-β-D-arabinofuranosylcytosine (CNDAC): Design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside. J. Med. Chem. 1991, 34, 2917-2919.
5. Tanaka, M.; Matsuda, A.; Terao, T.; Sasaki, T. Antitumor activity of a novel nucleoside, 2′-C-cyano-2′-deoxy-1-β-D-arabinofuranosylcytosine (CNDAC) against murine and human tumors. Cancer Lett. 1992, 64, 67-74.
6. Azuma, A.; Nakajima, Y.; Nishizono, N.; Minakawa, N.; Suzuki, M.; Hanaoka, K.; Kobayashi, T.; Tanaka, M.; Sasaki, T.; Matsuda, A. 2′-C-cyano-2′-deoxy-1-β-D-arabinofuranosylcytosine and its derivatives. A new class of nucleoside with a broad antitumor spectrum. J. Med. Chem. 1993, 36, 4183-4189.
7. Azuma, A.; Hanaoka, K.; Kurihara, A.; Kobayashi, T.; Miyauchi, S.; Kamo, N.; Tanaka, M.; Sasaki, T.; Matsuda, A. Chemical stability of a new antitumor nucleoside, 2′-C-cyano-2′-deoxy-1-β-D-arabinofuranosylcytosine in alkaline medium: Formation of 2′-C-cyano-2′-deoxy-1-β-D-ribofuranosylcytosine and its antitumor activity. J. Med. Chem. 1995, 38, 3391-3397.
8. McCarthy, J. R.; Matthews, D. P.; Stemerick, D. M.; Huber, E. W.; Bey, P.; Lippert, B. J.; Snyder, R. D.; Sunkara, P. S. Stereospecific method to E and Z terminal fluoro olefines and its application to the synthesis of 2′-deoxy-2′-fluoromethylene nucleosides as potential inhibitors of ribonucleoside diphosphate reductase. J. Am. Chem, Soc. 1991, 113, 7439-7440.
9. Hattori, H.; Tanaka, M.; Fukushima, M.; Sasaki, T.; Matsuda, A. 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity. J. Med. Chem. 1996, 39, 5005-5011.
10. Hattori, H.; Nozawa, E.; Iino, T.; Yoshimura, Y.; Shuto, S.; Shimamoto, Y.; Nomura, M.; Fukushima, M.; Tanaka, M.; Sasaki, T.; Matsuda, A. Structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine and -uracil. J. Med. Chem. 1998, 41, 2892-2902.
11. Takatori, S.; Kanda, H.; Takenaka, K.; Wataya, Y.; Matsuda, A.; Fukushima, M.; Shimamoto, Y.; Tanaka, M.; Sasaki, T. Antitumor mechanisms and metabolism of novel antitumor nucleoside analogues, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)-cytosine and 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)uracil. Cancer Chemother. Pharmacol., in press.
12. Waga, T.; Nishizaki, T.; Miyakawa, I.; Ohrui, H.; Meguro, H. Synthesis of 4′-C-methylnucleosides. Biosci. Biotechnol. Biochem. 1993, 57, 1433-1438.
13. Waga, T.; Ohrui, H.; Meguro, H. Synthesis and biological evaluation of 4′-C-methylnucleosides. Nucleosides Nucleotides 1996, 15, 287-304.
14. Kitano, K.; Miura, S.; Ohrui, H.; Meguro, H. Synthesis of 4′-C-fluoromethylnucleosides as potential antineoplastic agents. Tetrahedron 1997, 53, 13315-13322.
15. Sugimoto, I.; Shuto, S.; Mori, S.; Shigeta, S.; Matsuda, A. Synthesis of 4′-α-branched thymidines as a new type of antiviral agent. Bioorg. Med. Chem. Lett. 1999, 9, 385-388.
16. O-Yang, C.; Wu, H. Y.; Fraser-Smith, E. B.; Walker, K. A. M. Synthesis of 4′-cyanothymidine and analogues as potent inhibitors of HIV. Tetrahedron Lett. 1992, 33, 37-40.
17. Youssefyeh, R. D.; Tegg, D.; Verheyden, J. P. H.; Jones, G. H.; Moffatt, J. G. Synthetic routes to 4′-hydroxymethylnucleosides. Tetrahedron Lett. 1977, 435-438.
18. Youssefyeh, R. D.; Verheyden, J. P. H.; Moffatt, J. G. 4′-Substituted nucleosides. 4. Synthesis of some 4′-hydroxymethyl nucleosides. J. Org. Chem. 1979, 44, 1301-1306.
19. Jones, G. H.; Taniguchi, M.; Tegg, D.; Moffatt, J. G. 4′-Substituted nucleosides. 5. Hydroxymethylation of nucleoside 5′-aldehyde. J. Org. Chem. 1979, 44, 1309-1317.
20. Marx, A.; Erdmann, P.; Senn, M.; Körner, S.; Jungo, T.; Petretta, M.; Imwinkelried, P.; Dussy, A.; Kulicke, K. J.; Macko, L.; Zehnder, M.; Giese, B. Synthesis of 4′-C-acylated thymidines. Helv. Chim. Acta 1996, 79, 1980-1994.
21. O-Yang, C.; Kurtz, W.; Eugui, E. M.; McRoberts, M. J.; Verheyden, J. P. H.; Kurtz, L. J.; Walker, K. A. M. 4′-Substituted nucleosides as inhibitors of HIV: An unusual oxetane derivative. Tetrahedron Lett. 1992, 33, 41-44.
22. Carmichael, J.; DeGraff, W. G.; Gazdar, A. F.; Minna, J. D.; Mitchell, J. B. Evaluation of a tetrazolium-based semiaautomated colorimetric assay. Assessment of chemosensitivity testing. Cancer Res. 1987, 47, 936-942.
23. Takeuchi, H.; Baba, M.; Shigeta, S. An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds. J. Virol. Methods 1991, 33, 61-71.
24. Pauwels, R.; Balzarini, J.; Baba, M.; Snoeck, R.; Schols, D.; Herdwijn, P.; Desmyter, J.; De Clercq, E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 1988, 20, 309-321.